Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.42 - $3.65 $215,423 - $324,915
-89,018 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.82 - $3.7 $30,238 - $39,675
10,723 Added 13.7%
89,018 $287,000
Q2 2021

Aug 16, 2021

SELL
$3.5 - $5.48 $105,700 - $165,496
-30,200 Reduced 27.84%
78,295 $280,000
Q1 2021

May 17, 2021

SELL
$3.16 - $4.89 $1.41 Million - $2.18 Million
-445,559 Reduced 80.42%
108,495 $383,000
Q4 2020

Feb 16, 2021

SELL
$2.2 - $4.45 $383,099 - $774,905
-174,136 Reduced 23.91%
554,054 $1.76 Million
Q3 2020

Nov 16, 2020

BUY
$2.62 - $4.78 $1.38 Million - $2.52 Million
526,829 Added 261.63%
728,190 $2.94 Million
Q2 2020

Aug 14, 2020

BUY
$1.83 - $3.16 $368,490 - $636,300
201,361 New
201,361 $540,000
Q1 2019

May 15, 2019

SELL
$0.94 - $2.47 $29,096 - $76,456
-30,954 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.57 - $1.53 $8,664 - $23,256
15,200 Added 96.48%
30,954 $27,000
Q3 2018

Nov 14, 2018

BUY
$1.44 - $3.13 $22,685 - $49,310
15,754 New
15,754 $25,000
Q2 2018

Aug 14, 2018

SELL
$2.92 - $5.1 $56,096 - $97,976
-19,211 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.42 - $5.35 $65,701 - $102,778
19,211 New
19,211 $87,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $173M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.